Global Rubella Diagnostic Testing Market Insights, Forecast to 2029

Publication ID:

PB504237729

Publication Date:

May 31, 2023

Pages:

105

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Rubella infection generally affects children and adults. This infection has a serious effect on pregnant women and may result in fetal death or congenital defects.
Market Analysis and Insights: Global Rubella Diagnostic Testing Market
The global Rubella Diagnostic Testing market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Geographically, the entire rubella diagnostic testing market is classified into North America, Europe, Asia Pacific, Latin America and MEA.
Report Includes
This report presents an overview of global market for Rubella Diagnostic Testing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Rubella Diagnostic Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Rubella Diagnostic Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rubella Diagnostic Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Rubella Diagnostic Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Rubella Diagnostic Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Beckman Coulter, Bio Rad Laboratories, Biogate Laboratories, BioMerieux SA, Cigna, Diagnostic Laboratory of Oklahoma, GlaxoSmithKline and HealthLink BC, etc.
By Company
Abbott Laboratories
Beckman Coulter
Bio Rad Laboratories
Biogate Laboratories
BioMerieux SA
Cigna
Diagnostic Laboratory of Oklahoma
GlaxoSmithKline
HealthLink BC
Mayo Clinic
Ortho Clinical Diagnostics
True Health
Segment by Type
Flow Cytometry
Latex Slide Agglutination Test
Monoclonal Antibodies
Immunoassays
Serological Testing
Clinical Evaluation
Segment by Application
Hospitals
Commercial
Physician Offices
Public Health Labs
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Rubella Diagnostic Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rubella Diagnostic Testing companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rubella Diagnostic Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Flow Cytometry
1.2.3 Latex Slide Agglutination Test
1.2.4 Monoclonal Antibodies
1.2.5 Immunoassays
1.2.6 Serological Testing
1.2.7 Clinical Evaluation
1.3 Market by Application
1.3.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Commercial
1.3.4 Physician Offices
1.3.5 Public Health Labs
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rubella Diagnostic Testing Market Perspective (2018-2029)
2.2 Global Rubella Diagnostic Testing Growth Trends by Region
2.2.1 Rubella Diagnostic Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Rubella Diagnostic Testing Historic Market Size by Region (2018-2023)
2.2.3 Rubella Diagnostic Testing Forecasted Market Size by Region (2024-2029)
2.3 Rubella Diagnostic Testing Market Dynamics
2.3.1 Rubella Diagnostic Testing Industry Trends
2.3.2 Rubella Diagnostic Testing Market Drivers
2.3.3 Rubella Diagnostic Testing Market Challenges
2.3.4 Rubella Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Rubella Diagnostic Testing by Players
3.1.1 Global Rubella Diagnostic Testing Revenue by Players (2018-2023)
3.1.2 Global Rubella Diagnostic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Rubella Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Rubella Diagnostic Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Rubella Diagnostic Testing Market Concentration Ratio
3.4.1 Global Rubella Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rubella Diagnostic Testing Revenue in 2022
3.5 Global Key Players of Rubella Diagnostic Testing Head office and Area Served
3.6 Global Key Players of Rubella Diagnostic Testing, Product and Application
3.7 Global Key Players of Rubella Diagnostic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rubella Diagnostic Testing Breakdown Data by Type
4.1 Global Rubella Diagnostic Testing Historic Market Size by Type (2018-2023)
4.2 Global Rubella Diagnostic Testing Forecasted Market Size by Type (2024-2029)
5 Rubella Diagnostic Testing Breakdown Data by Application
5.1 Global Rubella Diagnostic Testing Historic Market Size by Application (2018-2023)
5.2 Global Rubella Diagnostic Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Rubella Diagnostic Testing Market Size (2018-2029)
6.2 North America Rubella Diagnostic Testing Market Size by Type
6.2.1 North America Rubella Diagnostic Testing Market Size by Type (2018-2023)
6.2.2 North America Rubella Diagnostic Testing Market Size by Type (2024-2029)
6.2.3 North America Rubella Diagnostic Testing Market Share by Type (2018-2029)
6.3 North America Rubella Diagnostic Testing Market Size by Application
6.3.1 North America Rubella Diagnostic Testing Market Size by Application (2018-2023)
6.3.2 North America Rubella Diagnostic Testing Market Size by Application (2024-2029)
6.3.3 North America Rubella Diagnostic Testing Market Share by Application (2018-2029)
6.4 North America Rubella Diagnostic Testing Market Size by Country
6.4.1 North America Rubella Diagnostic Testing Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Rubella Diagnostic Testing Market Size by Country (2018-2023)
6.4.3 North America Rubella Diagnostic Testing Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Rubella Diagnostic Testing Market Size (2018-2029)
7.2 Europe Rubella Diagnostic Testing Market Size by Type
7.2.1 Europe Rubella Diagnostic Testing Market Size by Type (2018-2023)
7.2.2 Europe Rubella Diagnostic Testing Market Size by Type (2024-2029)
7.2.3 Europe Rubella Diagnostic Testing Market Share by Type (2018-2029)
7.3 Europe Rubella Diagnostic Testing Market Size by Application
7.3.1 Europe Rubella Diagnostic Testing Market Size by Application (2018-2023)
7.3.2 Europe Rubella Diagnostic Testing Market Size by Application (2024-2029)
7.3.3 Europe Rubella Diagnostic Testing Market Share by Application (2018-2029)
7.4 Europe Rubella Diagnostic Testing Market Size by Country
7.4.1 Europe Rubella Diagnostic Testing Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Rubella Diagnostic Testing Market Size by Country (2018-2023)
7.4.3 Europe Rubella Diagnostic Testing Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Rubella Diagnostic Testing Market Size (2018-2029)
8.2 China Rubella Diagnostic Testing Market Size by Type
8.2.1 China Rubella Diagnostic Testing Market Size by Type (2018-2023)
8.2.2 China Rubella Diagnostic Testing Market Size by Type (2024-2029)
8.2.3 China Rubella Diagnostic Testing Market Share by Type (2018-2029)
8.3 China Rubella Diagnostic Testing Market Size by Application
8.3.1 China Rubella Diagnostic Testing Market Size by Application (2018-2023)
8.3.2 China Rubella Diagnostic Testing Market Size by Application (2024-2029)
8.3.3 China Rubella Diagnostic Testing Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Rubella Diagnostic Testing Market Size (2018-2029)
9.2 Asia Rubella Diagnostic Testing Market Size by Type
9.2.1 Asia Rubella Diagnostic Testing Market Size by Type (2018-2023)
9.2.2 Asia Rubella Diagnostic Testing Market Size by Type (2024-2029)
9.2.3 Asia Rubella Diagnostic Testing Market Share by Type (2018-2029)
9.3 Asia Rubella Diagnostic Testing Market Size by Application
9.3.1 Asia Rubella Diagnostic Testing Market Size by Application (2018-2023)
9.3.2 Asia Rubella Diagnostic Testing Market Size by Application (2024-2029)
9.3.3 Asia Rubella Diagnostic Testing Market Share by Application (2018-2029)
9.4 Asia Rubella Diagnostic Testing Market Size by Region
9.4.1 Asia Rubella Diagnostic Testing Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Rubella Diagnostic Testing Market Size by Region (2018-2023)
9.4.3 Asia Rubella Diagnostic Testing Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Rubella Diagnostic Testing Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rubella Diagnostic Testing Introduction
11.1.4 Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.1.5 Abbott Laboratories Recent Developments
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Rubella Diagnostic Testing Introduction
11.2.4 Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.2.5 Beckman Coulter Recent Developments
11.3 Bio Rad Laboratories
11.3.1 Bio Rad Laboratories Company Details
11.3.2 Bio Rad Laboratories Business Overview
11.3.3 Bio Rad Laboratories Rubella Diagnostic Testing Introduction
11.3.4 Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.3.5 Bio Rad Laboratories Recent Developments
11.4 Biogate Laboratories
11.4.1 Biogate Laboratories Company Details
11.4.2 Biogate Laboratories Business Overview
11.4.3 Biogate Laboratories Rubella Diagnostic Testing Introduction
11.4.4 Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.4.5 Biogate Laboratories Recent Developments
11.5 BioMerieux SA
11.5.1 BioMerieux SA Company Details
11.5.2 BioMerieux SA Business Overview
11.5.3 BioMerieux SA Rubella Diagnostic Testing Introduction
11.5.4 BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.5.5 BioMerieux SA Recent Developments
11.6 Cigna
11.6.1 Cigna Company Details
11.6.2 Cigna Business Overview
11.6.3 Cigna Rubella Diagnostic Testing Introduction
11.6.4 Cigna Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.6.5 Cigna Recent Developments
11.7 Diagnostic Laboratory of Oklahoma
11.7.1 Diagnostic Laboratory of Oklahoma Company Details
11.7.2 Diagnostic Laboratory of Oklahoma Business Overview
11.7.3 Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Introduction
11.7.4 Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.7.5 Diagnostic Laboratory of Oklahoma Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Rubella Diagnostic Testing Introduction
11.8.4 GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.8.5 GlaxoSmithKline Recent Developments
11.9 HealthLink BC
11.9.1 HealthLink BC Company Details
11.9.2 HealthLink BC Business Overview
11.9.3 HealthLink BC Rubella Diagnostic Testing Introduction
11.9.4 HealthLink BC Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.9.5 HealthLink BC Recent Developments
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Details
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic Rubella Diagnostic Testing Introduction
11.10.4 Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.10.5 Mayo Clinic Recent Developments
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Details
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics Rubella Diagnostic Testing Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.11.5 Ortho Clinical Diagnostics Recent Developments
11.12 True Health
11.12.1 True Health Company Details
11.12.2 True Health Business Overview
11.12.3 True Health Rubella Diagnostic Testing Introduction
11.12.4 True Health Revenue in Rubella Diagnostic Testing Business (2018-2023)
11.12.5 True Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott Laboratories
Beckman Coulter
Bio Rad Laboratories
Biogate Laboratories
BioMerieux SA
Cigna
Diagnostic Laboratory of Oklahoma
GlaxoSmithKline
HealthLink BC
Mayo Clinic
Ortho Clinical Diagnostics
True Health

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂